Related Experiment Video
Updated: Jun 8, 2026
Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury
Published on: September 11, 2017
TNF-α in CRPS and 'normal' trauma--significant differences between tissue and serum
Heidrun H Krämer1, Tatiana Eberle, Nurcan Üçeyler
1Department of Neurology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany Department of Trauma Surgery and Orthopedics, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany Department of Neurology, University of Würzburg, Germany.
Tumor necrosis factor-alpha (TNF-alpha) is elevated in the skin of patients with complex regional pain syndrome (CRPS) and acute fractures, but not systemically. This localized increase suggests targeted therapies for post-traumatic pain.
Area of Science:
- Biochemistry
- Immunology
- Pain Medicine
Background:
- Tumor necrosis factor-alpha (TNF-alpha) signaling is implicated in post-traumatic pain and hyperalgesia, particularly in complex regional pain syndromes (CRPS).
- Understanding the specific role of TNF-alpha in CRPS pathogenesis requires investigation of its localized and systemic concentrations following trauma.
Purpose of the Study:
- To investigate and compare skin and serum TNF-alpha concentrations in patients with osteoarthritis, acute upper limb bone fractures, and CRPS I.
- To elucidate the role of localized versus systemic TNF-alpha in the pathophysiology of CRPS.
Main Methods:
- Recruitment of 30 patients across three groups: osteoarthritis (n=10), acute fracture (n=10), and CRPS I (n=10).
- Collection of skin punch biopsies and serum samples prior to surgery or from the affected limb in CRPS patients.
- Quantification of skin and serum TNF-alpha levels using Enzyme-Linked Immunosorbent Assay (ELISA).
Main Results:
- Skin TNF-alpha levels were significantly elevated in CRPS patients (p<0.001) and fracture patients (p<0.04) compared to osteoarthritis patients.
- Skin TNF-alpha was notably higher in CRPS patients than in acute fracture patients (p<0.02).
- Serum TNF-alpha levels showed no significant difference between osteoarthritis and CRPS patients, but were lower in fracture patients (p<0.03).
Conclusions:
- Results indicate a localized increase in skin TNF-alpha in CRPS patients, persisting months after limb trauma.
- The findings suggest that elevated local TNF-alpha, rather than systemic levels, may contribute to pain and hyperalgesia in CRPS.
- This localized elevation presents a potential target for developing specific therapeutic interventions for CRPS.
